Prevalence and Risk Factors of Stroke in Inpatients with Type 2 Diabetes Mellitus in China

Abstract

Objective

The prevalence and the cluster characteristics of risk factors of stroke were assessed in a Chinese diabetic population.

Methods

Clinical data of 30 693 inpatients who were diagnosed with type 2 diabetes mellitus (T2DM) and admitted between 2013 and 2018 were retrospectively analyzed. The age-standardized prevalence of stroke was estimated using the 2010 Chinese population census data, and risk factors were analyzed by multiple imputation and regression.

Results

The crude and standardized prevalence rates of stroke in patients with T2DM were 34.4% and 21.5%, respectively, and 85.2% of the stroke patients had ischemic stroke. Nearly half of the patients who experienced stroke had clusters of more than 4 risk factors. Compared with no-risk-factor clustering, the risk of stroke significantly increased 3–4 times in the presence of more than 4 risk-factor clusters (P<0.001). Hypertension was the most common major risk factor for ischemic stroke [odds ratio (OR), 2.34; 95% confidence interval (CI), 2.18–2.50] and hemorrhagic stroke (OR, 3.68; 95% CI 2.95–4.59; P<0.001). Moreover, a 1-standard-deviation increase in fasting blood glucose (FBG) was significantly negatively correlated with ischemic stroke risk, and the same change in FBG was significantly associated with an 8% increased risk of hemorrhagic stroke.

Conclusion

The prevalence of stroke in patients with T2DM is rather high, and the clustering of risk factors is associated with the development of stroke in T2DM patients. Risk factors differ in different stroke subtypes. Identifying risk factors for a specific high-risk group is necessary.

References

[1] Magliano D, Boyko E. IDF Diabetes Atlas 10th edition scientific committee [Internet]. IDF Diabetes Atlas 2021. [2021-11-08]. Available from: https://diabetesatlas.org/data/en/

[2] BraggF, HolmesMV, IonaA, et al.. Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. JAMA, 2017, 317(3): 280-289

[3] FoxCS, CoadyS, SorliePD, et al.. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation, 2007, 115(12): 1544-1550

[4] O’DonnellMJ, ChinSL, RangarajanS, et al.. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet, 2016, 388(10046): 761-775

[5] Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2019,18(5):439–458

[6] ZhouM, WangH, ZhuJ, et al.. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016, 387(10015): 251-272

[7] MorrenJA, SalgadoED. Prevalence and control of stroke risk factors in a South Florida population. Int J Neurosci, 2012, 122(12): 734-741

[8] ShaheenHA, Abdel WahedWY, HasaneenST. Prevalence of Stroke in Fayoum Governorate, Egypt: A Community-Based Study. J Stroke Cerebrovasc Dis, 2019, 28(9): 2414-2420

[9] SusmithaK, ChandrasekharV, KiranG, et al.. Prevalence of Stroke Cases in Warangal, Telangana Region, India: A Hospital-Based Case Study. Adv Exp Med Biol, 2020, 1196: 109-115

[10] Al-OzairiE, JalloMK, HafidhK, et al.. Prevalence of Cardiovascular and Renal Comorbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study. Diabetes Ther, 2021, 12(4): 1193-1207

[11] LeeCH, WuYL, KuoJF, et al.. Prevalence of diabetic macrovascular complications and related factors from 2005 to 2014 in Taiwan: A nationwide survey. J Formos Med Assoc, 2019, 118(Suppl2): S96-S102

[12] ZhaoD, LiuJ, WangW, et al.. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke, 2008, 39(6): 1668-1674

[13] LyuY, LuoY, LiC, et al.. Regional Differences in the Prevalence of Coronary Heart Disease and Stroke in Patients With Type 2 Diabetes in China. J Clin Endocrinol Metab, 2018, 103(9): 3319-3330

[14] StollováM, SchuckO, SmrckováI, et al.. The auxiliary table for GFR estimation according to the MDRD formula. J Ren Care, 2008, 34(1): 43-44

[15] LiY, TengD, ShiX, et al.. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross-sectional study. BMJ, 2020, 369: m997

[16] WangW, JiangB, SunH, et al.. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation, 2017, 135(8): 759-771

[17] LiY, YangL, WangL, et al.. Burden of hypertension in China: A nationally representative survey of 174,621 adults. Int J Cardiol, 2017, 227: 516-523

[18] YusufS, JosephP, RangarajanS, et al.. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet, 2020, 395(10226): 795-808

[19] MertensBJA, BanzatoE, de WreedeLC. Construction and assessment of prediction rules for binary outcome in the presence of missing predictor data using multiple imputation and cross-validation: Methodological approach and data-based evaluation. Biom J, 2020, 62(3): 724-741

[20] FeiginVL, LawesCM, BennettDA, et al.. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003, 2(1): 43-53

[21] SiveniusJ, TuomilehtoJ, Immonen-RäihäP, et al.. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke, 2004, 35(2): 420-425

[22] HeuschmannPU, GrieveAP, ToschkeAM, et al.. Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke, 2008, 39(8): 2204-2210

[23] VenketasubramanianN, YoonBW, PandianJ, et al.. Stroke Epidemiology in South, East, and South–East Asia: A Review. J Stroke, 2017, 19(3): 286-294

[24] SetyopranotoI, BayuanggaHF, PanggabeanAS, et al.. Prevalence of Stroke and Associated Risk Factors in Sleman District of Yogyakarta Special Region, Indonesia. Stroke Res Treat, 2019, 2019: 2642458

[25] AdlerAI, StrattonIM, NeilHA, et al.. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ, 2000, 321(7258): 412-419

[26] TianJ, ShengCS, SunW, et al.. Effects of High Blood Pressure on Cardiovascular Disease Events Among Chinese Adults With Different Glucose Metabolism. Diabetes Care, 2018, 41(9): 1895-1900

[27] YuJG, ZhouRR, CaiGJ. From hypertension to stroke: mechanisms and potential prevention strategies. CNS Neurosci Ther, 2011, 17(5): 577-584

[28] EttehadD, EmdinCA, KiranA, et al.. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet, 2016, 387(10022): 957-967

[29] LarssonSC, WallinA, WolkA, et al.. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med, 2016, 14(1): 178

[30] Rask-MadsenC, KingGL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab, 2013, 17(1): 20-33

[31] SnarskaKK, Bachórzewska-GajewskaH, Kapica-TopczewskaK, et al.. Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke. Arch Med Sci, 2017, 13(1): 100-108

[32] NtaiosG, EgliM, FaouziM, et al.. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke, 2010, 41(10): 2366-2370

[33] RinkelLA, NguyenTTM, GuglielmiV, et al.. Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands (MR CLEAN) Registry Investigators. High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke. Stroke, 2020, 51(11): 3215-3223

[34] ORIGIN Trial InvestigatorsMellbinLG, RydénL, et al.. Does hypoglycemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J, 2013, 34(40): 3137-3144

[35] StrattonIM, AdlerAI, NeilHA, et al.. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 2000, 321(7258): 405-412

[36] LawesCM, ParagV, BennettDA, et al.. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care, 2004, 27(12): 2836-2842

[37] RiddleMC, AmbrosiusWT, BrillonDJ, et al.. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care, 2010, 33(5): 983-990

[38] DuckworthW, AbrairaC, MoritzT, et al.. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009, 360(2): 129-139

[39] GaedeP, VedelP, LarsenN, et al.. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003, 348(5): 383-393

[40] YusufS, HawkenS, OunpuuS, et al.. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 2004, 364(9438): 937-952

[41] JiL, HuD, PanC, et al.. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med, 2013, 126(10): 925

[42] GaedeP, Lund-AndersenH, ParvingHH, et al.. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 2008, 358(6): 580-591